Arrowhead Pharmaceuticals Stock Today

ARWR Stock  USD 28.60  0.10  0.35%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 9

 
100  
 
Zero
Low
Arrowhead Pharmaceuticals is selling at 28.60 as of the 29th of March 2024; that is -0.35% down since the beginning of the trading day. The stock's lowest day price was 28.04. Arrowhead Pharmaceuticals has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Arrowhead Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of February 2024 and ending today, the 29th of March 2024. Click here to learn more.
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California. Arrowhead Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 123.9 M outstanding shares of which 9.2 M shares are presently shorted by private and institutional investors with about 5.67 trading days to cover. More on Arrowhead Pharmaceuticals

Moving together with Arrowhead Stock

  0.65MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.61MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Arrowhead Stock

  0.5DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.46EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.41MESO Mesoblast TrendingPairCorr

Arrowhead Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Arrowhead Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Arrowhead Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOChristopher Anzalone
Business ConcentrationPharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Arrowhead Pharmaceuticals (ARWR) is traded on NASDAQ Exchange in USA. It is located in 177 East Colorado Boulevard, Pasadena, CA, United States, 91105 and employs 525 people. Arrowhead Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.56 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arrowhead Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Arrowhead Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Arrowhead Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 123.9 M outstanding shares of which 9.2 M shares are presently shorted by private and institutional investors with about 5.67 trading days to cover. Arrowhead Pharmaceuticals currently holds about 416.5 M in cash with (153.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.93.
Check Arrowhead Pharmaceuticals Probability Of Bankruptcy
Ownership Allocation
Arrowhead Pharmaceuticals retains a total of 123.9 Million outstanding shares. Over half of Arrowhead Pharmaceuticals' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Arrowhead Pharmaceuticals. Please watch out for any change in the institutional holdings of Arrowhead Pharmaceuticals as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Arrowhead Ownership Details

Arrowhead Stock Price Odds Analysis

In regard to a normal probability distribution, the odds of Arrowhead Pharmaceuticals jumping above the current price in 90 days from now is about 86.7%. The Arrowhead Pharmaceuticals probability density function shows the probability of Arrowhead Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.6194. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Arrowhead Pharmaceuticals will likely underperform. Additionally, arrowhead Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 28.6HorizonTargetOdds Above 28.6
13.22%90 days
 28.60 
86.70%
Based on a normal probability distribution, the odds of Arrowhead Pharmaceuticals to move above the current price in 90 days from now is about 86.7 (This Arrowhead Pharmaceuticals probability density function shows the probability of Arrowhead Stock to fall within a particular range of prices over 90 days) .

Arrowhead Pharmaceuticals Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Arrowhead Pharmaceuticals market risk premium is the additional return an investor will receive from holding Arrowhead Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Arrowhead Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Arrowhead Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Arrowhead Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.

Arrowhead Stock Against Markets

Picking the right benchmark for Arrowhead Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Arrowhead Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Arrowhead Pharmaceuticals is critical whether you are bullish or bearish towards Arrowhead Pharmaceuticals at a given time. Please also check how Arrowhead Pharmaceuticals' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Arrowhead Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Holdings Now

   

Portfolio Holdings

Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
All  Next Launch Module

Arrowhead Pharmaceuticals Corporate Directors

Arrowhead Pharmaceuticals corporate directors refer to members of an Arrowhead Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Arrowhead Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Arrowhead Pharmaceuticals' board members must vote for the resolution. The Arrowhead Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Charles McKenneyIndependent DirectorProfile
Michael PerryIndependent DirectorProfile
William WaddillIndependent DirectorProfile
Douglass GivenDirectorProfile

How to buy Arrowhead Stock?

Before investing in Arrowhead Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Arrowhead Pharmaceuticals. To buy Arrowhead Pharmaceuticals stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Arrowhead Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Arrowhead Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Arrowhead Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Arrowhead Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Arrowhead Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Arrowhead Stock please use our How to Invest in Arrowhead Pharmaceuticals guide.

Already Invested in Arrowhead Pharmaceuticals?

The danger of trading Arrowhead Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Arrowhead Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Arrowhead Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Arrowhead Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Arrowhead Pharmaceuticals is a strong investment it is important to analyze Arrowhead Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Arrowhead Pharmaceuticals' future performance. For an informed investment choice regarding Arrowhead Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arrowhead Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Arrowhead Stock analysis

When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is Arrowhead Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharmaceuticals. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Arrowhead Pharmaceuticals is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharmaceuticals' market value can be influenced by many factors that don't directly affect Arrowhead Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arrowhead Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.